BioLargo Inc made an important move towards building a commercial network for its sale and distribution as it signed a manufacturer's representative agreement with ICS Group— a premier manufacturer's representative company that has provided innovative wastewater, energy management, and renewable energy technology solutions to municipal and industrial clients, primarily in the Midwestern United States.
Under the agreement, ICS Group has been tasked to sell BioLargo’s two proprietary water treatment technologies, the advanced oxidation system (AOS) energy-efficient wastewater disinfection, micropollutant removal, and water reuse technology, and the aqueous electrostatic concentrator (AEC) technology for affordable, low-waste treatment of PFAS-contaminated water.
READ: BioLargo Inc subsidiary Clyra Medical's COVID-19-inactivating spray Clyraguard now available to the public
"We always strive to bring cutting-edge technologies to the market that help our clients achieve challenging treatment objectives. BioLargo's unique technology platforms definitely bring that capability to our treatment solutions," said Paul Nygaard, President of ICS Group, in a statement.
BioLargo invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water, and wastewater treatment, industrial odor, and VOC control, air quality control, and infection control.
"ICS Group has a reputation of outstanding customer service, making them the perfect choice to be our first manufacturer's representative for our technologies. They're also known for taking on new and innovative technologies that address unmet needs in the water treatment marketplace," said Tonya Chandler, BioLargo's director of strategic marketing and business development. "We intend to add more sales representatives soon and hope they will be as great a fit as the ICS Group to our values."
Contact Ritika at ritika@proactiveinvestors.com